Sutro Biopharma IncNASDAQ:STRO
- LAST PRICE4.2250
- TODAY'S CHANGE (%)-0.1050 (-2.4249%)
- Bid / Lots4.1400/ 20
- Ask / Lots4.2200/ 10
- Open / Previous Close4.3500 / 4.3300
- Day Range
- 52 Week Range
- Volume444,305
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | STRO |
|---|---|---|
| 09:32 ET | 5784 | 4.36 |
| 09:36 ET | 520 | 4.3301 |
| 09:38 ET | 600 | 4.39 |
| 09:39 ET | 200 | 4.4 |
| 09:41 ET | 2437 | 4.435 |
| 09:43 ET | 120 | 4.43 |
| 09:45 ET | 900 | 4.43 |
| 09:48 ET | 2300 | 4.445 |
| 09:50 ET | 1547 | 4.44 |
| 09:52 ET | 200 | 4.43 |
| 09:54 ET | 3080 | 4.435 |
| 09:56 ET | 800 | 4.425 |
| 09:57 ET | 700 | 4.41 |
| 09:59 ET | 500 | 4.41 |
| 10:01 ET | 5440 | 4.41 |
| 10:03 ET | 2302 | 4.425 |
| 10:06 ET | 800 | 4.41 |
| 10:08 ET | 611 | 4.4051 |
| 10:12 ET | 200 | 4.39 |
| 10:14 ET | 870 | 4.38 |
| 10:15 ET | 580 | 4.38 |
| 10:17 ET | 504 | 4.395 |
| 10:21 ET | 1397 | 4.415 |
| 10:24 ET | 200 | 4.415 |
| 10:26 ET | 400 | 4.4 |
| 10:28 ET | 217 | 4.395 |
| 10:30 ET | 100 | 4.395 |
| 10:32 ET | 974 | 4.384 |
| 10:35 ET | 3393 | 4.375 |
| 10:37 ET | 300 | 4.375 |
| 10:39 ET | 200 | 4.385 |
| 10:44 ET | 200 | 4.38 |
| 10:46 ET | 692 | 4.365 |
| 10:48 ET | 5274 | 4.34 |
| 10:51 ET | 200 | 4.33 |
| 10:53 ET | 200 | 4.33 |
| 10:55 ET | 706 | 4.33 |
| 10:57 ET | 900 | 4.35 |
| 11:00 ET | 200 | 4.34 |
| 11:02 ET | 504 | 4.335 |
| 11:06 ET | 239 | 4.3151 |
| 11:08 ET | 100 | 4.32 |
| 11:09 ET | 2440 | 4.34 |
| 11:11 ET | 8068 | 4.355 |
| 11:13 ET | 200 | 4.35 |
| 11:15 ET | 732 | 4.33 |
| 11:18 ET | 100 | 4.325 |
| 11:20 ET | 100 | 4.325 |
| 11:22 ET | 200 | 4.305 |
| 11:24 ET | 500 | 4.31 |
| 11:26 ET | 229 | 4.31 |
| 11:27 ET | 100 | 4.315 |
| 11:31 ET | 343 | 4.31 |
| 11:33 ET | 100 | 4.31 |
| 11:36 ET | 21708 | 4.315 |
| 11:38 ET | 4308 | 4.31 |
| 11:40 ET | 1884 | 4.3199 |
| 11:42 ET | 100 | 4.315 |
| 11:44 ET | 300 | 4.3 |
| 11:45 ET | 11695 | 4.3233 |
| 11:47 ET | 842 | 4.32 |
| 11:49 ET | 800 | 4.315 |
| 11:54 ET | 1100 | 4.305 |
| 11:56 ET | 1607 | 4.28 |
| 11:58 ET | 18573 | 4.2879 |
| 12:00 ET | 25670 | 4.27 |
| 12:02 ET | 2687 | 4.26 |
| 12:03 ET | 250 | 4.2576 |
| 12:05 ET | 100 | 4.255 |
| 12:07 ET | 729 | 4.24 |
| 12:09 ET | 1200 | 4.24 |
| 12:12 ET | 2050 | 4.2397 |
| 12:14 ET | 14585 | 4.2201 |
| 12:16 ET | 1500 | 4.23 |
| 12:18 ET | 1400 | 4.24 |
| 12:20 ET | 240 | 4.25 |
| 12:21 ET | 700 | 4.225 |
| 12:23 ET | 1380 | 4.21 |
| 12:25 ET | 5513 | 4.2071 |
| 12:27 ET | 700 | 4.215 |
| 12:30 ET | 7900 | 4.215 |
| 12:32 ET | 300 | 4.205 |
| 12:34 ET | 600 | 4.21 |
| 12:36 ET | 1000 | 4.2197 |
| 12:38 ET | 100 | 4.21 |
| 12:39 ET | 620 | 4.205 |
| 12:41 ET | 700 | 4.21 |
| 12:43 ET | 1700 | 4.205 |
| 12:45 ET | 300 | 4.205 |
| 12:48 ET | 300 | 4.21 |
| 12:50 ET | 900 | 4.195 |
| 12:56 ET | 200 | 4.205 |
| 12:57 ET | 100 | 4.205 |
| 12:59 ET | 700 | 4.21 |
| 01:01 ET | 2113 | 4.23 |
| 01:03 ET | 100 | 4.235 |
| 01:06 ET | 515 | 4.22 |
| 01:08 ET | 900 | 4.215 |
| 01:10 ET | 500 | 4.215 |
| 01:12 ET | 100 | 4.22 |
| 01:15 ET | 300 | 4.215 |
| 01:17 ET | 300 | 4.215 |
| 01:21 ET | 100 | 4.205 |
| 01:24 ET | 400 | 4.215 |
| 01:26 ET | 1516 | 4.215 |
| 01:28 ET | 300 | 4.215 |
| 01:30 ET | 300 | 4.215 |
| 01:32 ET | 566 | 4.2095 |
| 01:37 ET | 200 | 4.2 |
| 01:39 ET | 1435 | 4.195 |
| 01:44 ET | 200 | 4.195 |
| 01:46 ET | 400 | 4.205 |
| 01:48 ET | 100 | 4.205 |
| 01:50 ET | 900 | 4.195 |
| 01:53 ET | 1183 | 4.19 |
| 01:55 ET | 100 | 4.185 |
| 02:00 ET | 3158 | 4.17 |
| 02:02 ET | 1100 | 4.17 |
| 02:04 ET | 200 | 4.17 |
| 02:06 ET | 4838 | 4.165 |
| 02:08 ET | 4000 | 4.18 |
| 02:09 ET | 100 | 4.175 |
| 02:11 ET | 2713 | 4.1781 |
| 02:13 ET | 100 | 4.18 |
| 02:15 ET | 100 | 4.18 |
| 02:18 ET | 600 | 4.185 |
| 02:20 ET | 1500 | 4.19 |
| 02:24 ET | 400 | 4.185 |
| 02:26 ET | 100 | 4.19 |
| 02:27 ET | 841 | 4.175 |
| 02:29 ET | 486 | 4.17 |
| 02:31 ET | 5648 | 4.16 |
| 02:33 ET | 1160 | 4.16 |
| 02:36 ET | 400 | 4.16 |
| 02:38 ET | 1345 | 4.155 |
| 02:40 ET | 762 | 4.155 |
| 02:42 ET | 200 | 4.15 |
| 02:44 ET | 100 | 4.15 |
| 02:45 ET | 761 | 4.165 |
| 02:49 ET | 816 | 4.16 |
| 02:51 ET | 992 | 4.155 |
| 02:54 ET | 800 | 4.145 |
| 02:56 ET | 300 | 4.15 |
| 02:58 ET | 1097 | 4.15 |
| 03:02 ET | 300 | 4.145 |
| 03:03 ET | 2400 | 4.14 |
| 03:05 ET | 700 | 4.1499 |
| 03:07 ET | 150 | 4.1499 |
| 03:09 ET | 2918 | 4.17 |
| 03:12 ET | 1000 | 4.16 |
| 03:14 ET | 200 | 4.165 |
| 03:16 ET | 100 | 4.165 |
| 03:18 ET | 1227 | 4.16 |
| 03:20 ET | 1989 | 4.155 |
| 03:21 ET | 2100 | 4.1501 |
| 03:23 ET | 250 | 4.155 |
| 03:25 ET | 100 | 4.15 |
| 03:27 ET | 4486 | 4.2 |
| 03:30 ET | 971 | 4.185 |
| 03:32 ET | 600 | 4.165 |
| 03:34 ET | 100 | 4.165 |
| 03:36 ET | 720 | 4.17 |
| 03:38 ET | 100 | 4.175 |
| 03:39 ET | 300 | 4.175 |
| 03:41 ET | 3859 | 4.18 |
| 03:43 ET | 2000 | 4.185 |
| 03:45 ET | 2732 | 4.195 |
| 03:48 ET | 1100 | 4.195 |
| 03:50 ET | 100 | 4.195 |
| 03:52 ET | 2591 | 4.215 |
| 03:54 ET | 4015 | 4.225 |
| 03:56 ET | 470 | 4.225 |
| 03:57 ET | 1789 | 4.215 |
| 03:59 ET | 3752 | 4.225 |
May 15, 2024
DJ Sutro Biopharma Is Maintained at Outperform by Oppenheimer, from 11:47AM ET on Wednesday May 15, 2024 by Dow Jones
11:47AM ET on Wednesday May 15, 2024 by Dow Jones
May 14, 2024
DJ Sutro Biopharma Price Target Maintained With a $8.00/Share by Wedbush, from 8:41AM ET on Tuesday May 14, 2024 by Dow Jones
8:41AM ET on Tuesday May 14, 2024 by Dow JonesDJ Sutro Biopharma Price Target Maintained With a $12.00/Share by HC Wainwright & Co., from 7:28AM ET on Tuesday May 14, 2024 by Dow Jones
7:28AM ET on Tuesday May 14, 2024 by Dow Jones
May 13, 2024
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones, from 4:30PM ET on Monday May 13, 2024 by Dow Jones
4:30PM ET on Monday May 13, 2024 by Dow Jones*DJ Sutro Biopharma 1Q Loss/Shr 95c >STRO, from 4:30PM ET on Monday May 13, 2024 by Dow Jones
4:30PM ET on Monday May 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sutro Biopharma Inc | 354.2M | -2.2x | --- |
Agenus Inc | 317.3M | -1.2x | --- |
Anika Therapeutics Inc | 381.2M | -4.9x | --- |
Kamada Ltd | 300.0M | 20.6x | -22.48% |
Avid Bioservices Inc | 504.7M | -28.5x | --- |
Travere Therapeutics Inc | 534.4M | -1.4x | --- |
Company Information
Sutro Biopharma, Inc. is a clinical-stage oncology company. The Company is engaged in developing site-specific and novel-format antibody drug conjugates (ADCs) enabled by its integrated cell-free protein synthesis platform, XpressCF, and its site-specific conjugation platform, XpressCF+. The Company’s advanced product candidate is STRO-002 (luveltamab tazevibulin, or luvelta), an ADC directed against folate receptor-alpha (FolRa), for patients with FolRa-expressing cancers, including ovarian cancer. In addition, it uses luvelta to treat pediatric patients with relapsed/refractory CBFA2T3-GLIS2 and acute myeloid leukemia. It also has two preclinical product candidates, STRO-003 and STRO-004. These product candidates are single homogeneous ADCs directed against an anti-receptor tyrosine kinase-like orphan receptor 1 (ROR1), and tissue factor (TF), each of which is being developed for the treatment of solid tumors.
Contact Information
- Headquarters
- 111 Oyster Point Blvd.SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-392-8412
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Connie Matsui
- President, Chief Operating Officer
- Jane Chung
- Chief Executive Officer, Director
- William Newell
- Chief Financial Officer
- Edward Albini
- Chief People and Communications Officer
- Linda Fitzpatrick
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $354.2M |
|---|---|
Revenue (TTM) | $154.1M |
Shares Outstanding | 81.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.24 |
EPS | $-1.89 |
Book Value | $2.45 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 2.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -67.27% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
